0001127602-12-023397.txt : 20120801 0001127602-12-023397.hdr.sgml : 20120801 20120801164501 ACCESSION NUMBER: 0001127602-12-023397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120730 FILED AS OF DATE: 20120801 DATE AS OF CHANGE: 20120801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DODION PIERRE F CENTRAL INDEX KEY: 0001403174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 121000600 MAIL ADDRESS: STREET 1: ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-07-30 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001403174 DODION PIERRE F C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Corp. Dev. & Operations Common Stock 2012-07-30 4 M 0 25000 5.49 A 61640 D Common Stock 2012-07-30 4 S 0 28600 19.00 D 33040 D Employee Stock Option (Right to Buy) 5.49 2012-07-30 4 M 0 25000 0 D 2017-06-28 Common Stock 25000 25000 D Shares were acquired upon the exercise of outstanding stock options at $5.49 per share. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. These options vest 25% per year on each June 28, 2008, 2009, 2010 and 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-08-01